$8B Price Tag for PCOS; Tymlos Label Update; Genetic Obesity Tx Seeks New Approvals

Eli Lilly is voluntarily recalling one lot of the glucagon emergency kit for low blood sugar with an expiration of April 2022 due to loss of potency, the FDA announced.

The estimated cost to diagnose and treat women with polycystic ovary syndrome (PCOS) was $8 billion in the U.S. in 2020. “Although PCOS affects at least one in seven women and leads to over $8 billion in healthcare costs annually in the United States alone, it is frequently misunderstood or overlooked by clinicians and policymakers,” said study author Carrie Riestenberg, MD, of the University of California Los Angeles, in a statement. (Journal of Clinical Endocrinology & Metabolism)

After seeing positive findings in a pivotal clinical study, Retina-AI Health announced that it submitted an application to the FDA for clearance of the RETINA-AI Galaxy, its autonomous diabetic retinopathy screening device.

Losing weight also helped to preserve fertility in boys with obesity ages 10 to 18, reversing alterations of Leydig cells. (U.S. News & World Report)

Radius Health announced a label update for the postmenopausal osteoporosis treatment abaloparatide (Tymlos) to include new data on the drug’s mechanism of action, which now reads: “Once-daily administration of abaloparatide stimulates new bone formation on trabecular and cortical bone surfaces by stimulation of osteoblastic activity.”

Metformin was able to extend pregnancy by about another week in women with preterm pre-eclampsia. (The BMJ)

A new review supported intermittent fasting — only eating within an 8- to 10-hour window each day — as a viable method for weight and metabolic control. (Endocrine Reviews)

Rhythm Pharmaceuticals announced that it submitted a supplemental new drug application to the FDA seeking an expanded indication for its melanocortin 4 receptor (MC4R) agonist setmelanotide (Imcivree) to also include patients with Bardet-Biedl syndrome or Alström syndrome.

In related news, Rhythm also said that setmelanotide (Imcivree) — already FDA approved back in 2020 — has now been given the green light in Great Britain, indicated for chronic weight management in patients ages 6 and older with obesity due to confirmed POMC, PCSK1, or LEPR deficiency.

Bayer announced that its new FIND-CKD trial — a phase III study testing finerenone (Kerendia) on the progression of nondiabetic chronic kidney disease — is now underway. The anti-mineralocorticoid agent was approved in July to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attack, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.

Last Updated September 27, 2021

  • author

    Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
The Best Of New York Fashion Week thumbnail

The Best Of New York Fashion Week

For fashion aficionados like us, NYFW serves as an exciting prelude to the grandeur that awaits in the fashion capitals of Paris and Milan. It’s not just a teaser; it offers an enticing glimpse into the upcoming season. From the triumphant return of Ralph Lauren to the runway to the eagerly anticipated show by Helmut
Read More
Food safety  expert named by Court to resolve Amos Miller case thumbnail

Food safety expert named by Court to resolve Amos Miller case

Federal Judge Edward G. Smith has his man. Agricultural expert George David Lapsley was named Thursday by Smith as the Court’s expert in the 3-year old proceedings involving Amos Miller and Miller’s Organic Farm. The order gives Lapsley broad authority, including unimpeded access and power to make unannounced site visits to all Miller properties. Lapsley’s…
Read More
Screens and children, watch out for Christmas gifts thumbnail

Screens and children, watch out for Christmas gifts

Cuando se acercan las fechas navideñas, todos comenzamos a buscar el regalo ideal para cada miembro de nuestra familia. Pero si se hace un regalo a algún niño, hay que tener especial cuidado, ya que están en edades de desarrollo y crecimiento físico y psíquico, y la sobreexposición a un estímulo negativo, podría marcar su…
Read More
Diagnostic tests 'just to be on the safe side' not recommended thumbnail

Diagnostic tests ‘just to be on the safe side’ not recommended

High and low-guideline-concordant provider groups comparison of environmental, patient, and provider factors influencing unneeded LS-MRI. Credit: Journal of General Internal Medicine (2020). DOI: 10.1007/s11606-019-05410-y Paradoxical maybe, but it's what often happens in the health services: When you ask for an MRI to be on the safe side, your uncertainty increases, says Bjørn Hoffman, a professor
Read More
New NUHS AI can spot high blood calcium levels thumbnail

New NUHS AI can spot high blood calcium levels

The National University Health System has developed a new AI tool that can detect cases of hypercalcemia in real-time. WHAT IT DOES Dubbed CalSense, the AI screens blood calcium level reports across the organisation to flag hypercalcemia cases, which are then shown in real time via a live dashboard.  It also checks on other investigative
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?